Eva L. Feldman

57.9k total citations · 16 hit papers
573 papers, 41.5k citations indexed

About

Eva L. Feldman is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Eva L. Feldman has authored 573 papers receiving a total of 41.5k indexed citations (citations by other indexed papers that have themselves been cited), including 230 papers in Neurology, 206 papers in Physiology and 179 papers in Molecular Biology. Recurrent topics in Eva L. Feldman's work include Pain Mechanisms and Treatments (125 papers), Amyotrophic Lateral Sclerosis Research (91 papers) and Neurogenetic and Muscular Disorders Research (64 papers). Eva L. Feldman is often cited by papers focused on Pain Mechanisms and Treatments (125 papers), Amyotrophic Lateral Sclerosis Research (91 papers) and Neurogenetic and Muscular Disorders Research (64 papers). Eva L. Feldman collaborates with scholars based in United States, United Kingdom and Canada. Eva L. Feldman's co-authors include Brian C. Callaghan, Andrea M. Vincent, Bhumsoo Kim, Rodica Pop‐Busui, Vera Bril, James W. Russell, James W. Russell, Stacey A. Sakowski, Hsinlin T. Cheng and Andrew J.M. Boulton and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Eva L. Feldman

558 papers receiving 40.4k citations

Hit Papers

Diabetic Neuropathy: A Po... 1994 2026 2004 2015 2016 2005 1994 2019 2012 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diabetic Neuropathy: A Position Statement by the American Diabetes Association
    2016 1.6k citations Rodica Pop‐Busui, Eva L. Feldman et al. profile →
  2. Diabetic Neuropathies
    2005 1.4k citations Vera Bril, Eva L. Feldman et al. profile →
  3. A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy
    1994 995 citations Eva L. Feldman et al. profile →
  4. Diabetic neuropathy
    2019 978 citations Eva L. Feldman, Brian C. Callaghan et al. profile →
  5. Diabetic neuropathy: clinical manifestations and current treatments
    2012 808 citations Brian C. Callaghan, Eva L. Feldman et al. profile →
  6. Oxidative Stress in the Pathogenesis of Diabetic Neuropathy
    2004 755 citations Eva L. Feldman et al. profile →
  7. New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain
    2017 651 citations Eva L. Feldman et al. profile →
  8. Diabetic neuropathy: Mechanisms to management
    2008 586 citations Eva L. Feldman et al. profile →
  9. Amyotrophic lateral sclerosis
    2022 544 citations Eva L. Feldman, Stephen A. Goutman et al. profile →
  10. Evidence-based guideline: Treatment of painful diabetic neuropathy [RETIRED]
    2011 449 citations Vera Bril, J. England et al. Neurology profile →
  11. Enhanced glucose control for preventing and treating diabetic neuropathy
    2012 412 citations Brian C. Callaghan, Eva L. Feldman et al. profile →
  12. Neurological consequences of obesity
    2017 363 citations Lucy M. Hinder, Brian C. Callaghan et al. profile →
  13. New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism
    2019 331 citations Stéphanie Eid, Eva L. Feldman et al. profile →
  14. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis
    2022 231 citations Stephen A. Goutman, Masha G. Savelieff et al. profile →
  15. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments
    2022 196 citations Masha G. Savelieff, Brian C. Callaghan et al. profile →
  16. New perspectives in diabetic neuropathy
    2023 107 citations Stéphanie Eid, Amy E. Rumora et al. profile →

Peers

Eva L. Feldman
Comparison fields: 5 of 188
  • Physiology 16.3k
  • Neurology 13.1k
  • Molecular Biology 11.0k
  • Endocrinology, Diabetes and Metabolism 8.3k
  • Cellular and Molecular Neuroscience 6.4k
Replace Cornelia M. van Duijn with:
Cornelia M. van Duijn Netherlands
P. James B. Dyck United States
Nobutaka Hattori Japan
Berislav V. Zloković United States
Phillip A. Low United States
Allen D. Roses United States
Costantino Iadecola United States
Alberto Ascherio United States
Michael A. Moskowitz United States
Jeffery M. Vance United States
Cornelia M. van Duijn Netherlands View profile →
Citations per field, relative to Eva L. Feldman
Eva L. Feldman · 1×
Citations per year, relative to Eva L. Feldman
Eva L. Feldman · 1×

Countries citing papers authored by Eva L. Feldman

Since Specialization
Citations

This map shows the geographic impact of Eva L. Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva L. Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva L. Feldman more than expected).

Fields of papers citing papers by Eva L. Feldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva L. Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva L. Feldman. The network helps show where Eva L. Feldman may publish in the future.

Co-authorship network of co-authors of Eva L. Feldman

This figure shows the co-authorship network connecting the top 25 collaborators of Eva L. Feldman. A scholar is included among the top collaborators of Eva L. Feldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva L. Feldman. Eva L. Feldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
In Vitro Modeling of Natural Killer Cell Cytotoxicity to Inform Personalized ALS Therapeutics
2025 ·Annals of Clinical and Translational Neurology ·Benjamin J. Murdock, Jihyun Park, (unknown), (unknown), (unknown), (unknown), Lili Zhao, Eva L. Feldman, Stephen A. Goutman
1
2
Neuropathy and the metabolic syndrome
2024 ·eNeurologicalSci ·Nelson Sarto Piccolo, (unknown), (unknown), Eva L. Feldman
0
3
Gender Differences in Faculty Perceptions of Mentorship and Sponsorship
2024 ·JAMA Network Open ·(unknown), Kent A. Griffith, Isis H. Settles, Abigail J. Stewart, Eve A. Kerr, Eva L. Feldman, Reshma Jagsi
2
4
Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 Diabetes
2024 ·Journal of the American Heart Association ·Lynn Ang, (unknown), Yiyuan Huang, (unknown), Catherine L. Martin, (unknown), Jacob A. Reiss, Pennelope Blakely, Alexi Vasbinder, Lili Zhao, Kara Mizokami‐Stout, Ya‐ling Tang, Eva L. Feldman, Alessandro Doria, Cathie Spino, Mousumi Banerjee, Salim S. Hayek, Rodica Pop‐Busui
2
5
Burnout Among Mid-Career Academic Medical Faculty
2024 ·JAMA Network Open ·Kelly C. Paradis, Eve A. Kerr, Kent A. Griffith, (unknown), Eva L. Feldman, Kanakadurga Singer, Nancy D. Spector, Peter A. Ubel, Reshma Jagsi
3
6
Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions
2024 ·Annals of Neurology ·Stacey A. Sakowski, (unknown), Kevin S. Chen, Stephen A. Goutman, Eva L. Feldman
26
7
Human neural stem cells restore spatial memory in a transgenic Alzheimer’s disease mouse model by an immunomodulating mechanism
2023 ·Frontiers in Aging Neuroscience ·Kevin S. Chen, Mohamed H. Noureldein, Lisa M. McGinley, John M. Hayes, (unknown), (unknown), (unknown), Faye E. Mendelson, Masha G. Savelieff, Eva L. Feldman
7
8
Environmental risk scores of persistent organic pollutants associate with higher ALS risk and shorter survival in a new Michigan case/control cohort
2023 ·Journal of Neurology Neurosurgery & Psychiatry ·Stephen A. Goutman, Jonathan Boss, (unknown), Bhramar Mukherjee, Rudy J. Richardson, Stuart Batterman, Eva L. Feldman
18
9
Non‐invasive in vivo measurements of metabolic alterations in the type 2 diabetic brain by 1H magnetic resonance spectroscopy
2023 ·Journal of Neurochemistry ·In‐Young Choi, Wen‐Tung Wang, Bhumsoo Kim, Junguk Hur, David C. Robbins, (unknown), Masha G. Savelieff, Eva L. Feldman, Phil Lee
1
10
Gut microbiota in a mouse model of obesity and peripheral neuropathy associated with plasma and nerve lipidomics and nerve transcriptomics
2023 ·Microbiome ·Kai Guo, Claudia Figueroa‐Romero, Mohamed H. Noureldein, Lucy M. Hinder, Stacey A. Sakowski, Amy E. Rumora, (unknown), Masha G. Savelieff, Junguk Hur, Eva L. Feldman
19
11
Transcriptomic analysis of diabetic kidney disease and neuropathy in mouse models of type 1 and type 2 diabetes
2023 ·Disease Models & Mechanisms ·Sarah E. Elzinga, Stéphanie Eid, (unknown), (unknown), Lucy M. Hinder, Jacqueline R. Dauch, John M. Hayes, Hongyu Zhang, Kai Guo, Subramaniam Pennathur, Matthias Kretzler, Frank C. Brosius, (unknown), Eva L. Feldman, Junguk Hur
4
12
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact
2021 ·Neuroscience & Biobehavioral Reviews ·Fabiola De Marchi, Ivana Munitić, Amedeo Amedei, James D. Berry, Eva L. Feldman, Eleonora Aronica, Giovanni Nardo, Donatienne Van Weehaeghe, Elena Niccolai, (unknown), Stacey A. Sakowski, Caterina Bendotti, Letizia Mazzini
34
13
Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status
2021 ·The Journal of Clinical Endocrinology & Metabolism ·Kai Guo, Masha G. Savelieff, Amy E. Rumora, Fadhl Alakwaa, Brian C. Callaghan, Junguk Hur, Eva L. Feldman
28
14
Genome-wide DNA methylation profiling of human diabetic peripheral neuropathy in subjects with type 2 diabetes mellitus
2019 ·Epigenetics ·Kai Guo, Sarah E. Elzinga, Stéphanie Eid, Claudia Figueroa‐Romero, Lucy M. Hinder, Crystal Pacut, Eva L. Feldman, Junguk Hur
28
15
Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-I: A Novel Cellular Therapy for Alzheimer's Disease
2016 ·Stem Cells Translational Medicine ·Lisa M. McGinley, Erika Sims, J. Simon Lunn, Osama N. Kashlan, Kevin S. Chen, Elizabeth Bruno, Crystal Pacut, (unknown), Karl Johe, Stacey A. Sakowski, Eva L. Feldman
66
16
Longitudinal patient-oriented outcomes in neuropathy
2015 ·Neurology ·Brian C. Callaghan, Kevin A. Kerber, Kenneth M. Langa, Mousumi Banerjee, Ann Rodgers, Ryan J. McCammon, James Burke, Eva L. Feldman
36
17
Loss of Miro1-directed mitochondrial movement results in a novel murine model for neuron disease
2014 ·Proceedings of the National Academy of Sciences ·Tammy Nguyen, Sang Su Oh, David T. Weaver, Agnieszka Lewandowska, (unknown), Max-Hinderk Schuler, Nathan K. Smith, Jane L. Macfarlane, Gerald W. Saunders, Cheryl A. Palmer, Valentina Debattisti, Takumi Koshiba, Stefan M. Pulst, Eva L. Feldman, György Hajnóczky, Janet M. Shaw
171
18
Evidence-based guideline: Treatment of painful diabetic neuropathy [RETIRED] breakdown →
2011 ·Neurology ·Vera Bril, J. England, Gary M. Franklin, Miroslav Bačkonja, (unknown), David Del Toro, Eva L. Feldman, Donald Iverson, Bruce A. Perkins, James W. Russell, Douglas W. Zochodne
449
19
Caveolin-1 expression in Schwann cells
2006 ·Deep Blue (University of Michigan) ·Daniel D. Mikol, (unknown), Hsin-Lin Cheng, Eva L. Feldman
45
20
IGF and Nutrition in Health and Disease
2004 ·Humana Press eBooks ·(unknown), Jeffrey M P Holly, Eva L. Feldman, (unknown)
18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cornelia M. van Duijn Breakdown of academic impact, for papers by P. James B. Dyck Breakdown of academic impact, for papers by Nobutaka Hattori Breakdown of academic impact, for papers by Berislav V. Zloković Breakdown of academic impact, for papers by Phillip A. Low Breakdown of academic impact, for papers by Allen D. Roses Breakdown of academic impact, for papers by Costantino Iadecola Breakdown of academic impact, for papers by Alberto Ascherio Breakdown of academic impact, for papers by Michael A. Moskowitz Breakdown of academic impact, for papers by Jeffery M. Vance
Rankless by CCL
2026